DOI:
10.1055/s-00000002
Aktuelle Dermatologie
LinksClose Window
References
Hermans MAW, Schrijver B, van Holten-Neelen CCPA. et al.
The JAK1/JAK2- inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release.
Clin Exp Allergy 2018;
48: 1412-1420
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.